Hims & Hers Health (HIMS): insider & executive buying
Hims & Hers Health · Health Care · ref. ETF XLV · price $31.66
In short — 1 insider bought Hims & Hers Health over ~6 months (1 buy, total $1.2M, latest May 26, 26). Public Form 4 data, informative (not a performance signal).
Are Hims & Hers Health's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$31.66-28.2% over range
Aug 28, 25low $14.52 · high $62.76Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 12 analysts
Latest insider buys on Hims & Hers Health
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| May 26, 26 | Wells David B | Dir | 48,400 | $1.2M |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Hims & Hers Health's executives bought shares recently?
1 Hims & Hers Health insider(s) bought $1.2M over ~6 months (latest May 26, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for HIMS?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Hims & Hers Health? The JPI assistant answers using our backtest data.